Airain Ltd’s Pacira BioSciences PCRX Stock Holding History

Airain Ltd’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,946	Closed	-$538K	–	754
2016 Q2	$538K	Buy	+15,946	New	+$784K	0.03%	429
2016 Q1	–	Sell	-3,655	Closed	-$281K	–	1007
2015 Q4	$281K	Sell	3,655 -2,040	-36%	-$116K	0.02%	626
2015 Q3	$234K	Buy	+5,695	New	+$349K	0.01%	658
2015 Q2	–	Sell	-3,232	Closed	-$287K	–	1033
2015 Q1	$287K	Buy	+3,232	New	+$328K	0.02%	640

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Airain Ltd's PCRX Position: Q3 2016 in Review

Airain Ltd sold out of Pacira BioSciences (PCRX) in Q3 2016, closing a stake of 15,946 shares — an estimated $538K sold.

Airain Ltd first reported a position in PCRX in Q1 2015 and held it in 4 quarters. The position peaked at $538K in Q2 2016. 180 funds tracked by Wall St. Rank hold PCRX as of Q3 2016.

Airain Ltd reported no remaining Pacira BioSciences position as of Q3 2016 after selling out during the quarter.
Airain Ltd sold 15,946 Pacira BioSciences shares in Q3 2016, an estimated $538K.
Airain Ltd first reported a position in Pacira BioSciences in Q1 2015 and held it in 4 quarters.
Airain Ltd's Pacira BioSciences position peaked at $538K in Q2 2016.
180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2016.

Based on Airain Ltd's 13F filing for Q3 2016, filed 8 Nov 2016.